Professional Documents
Culture Documents
Lipid Metabolism 2 2018
Lipid Metabolism 2 2018
Triacylglycerol Phosphatidylserine
H O
H C O C (CH2)n CH3
O
H C O C (CH2)n CH3
O
H C O C (CH2)n CH3
• Phosphatidylcholine
• Phosphatidylethanolamine
• Phosphatidylserine
• Phosphatidylinositol
H2C-OH
Glycerol-3-Phosphate
HO-C-H
H2C-O- P
FA-CoA CoA
Acyl-CoA: glycerol phosphate 1-acyltransferase*
*prefers saturated fatty acids
H2C-O-FA1
Lysophosphatidate
HO-C-H
H2C-O- P
1st steps in TAG & PL synthesis are the same
H2C-O-FA1
Lysophosphatidate
HO-C-H
H2C-O- P
FA-CoA CoA
Acyl-CoA: 1-acyl glycerol phosphate 2-acyltransferase*
H2C-O-FA1
Phosphatidate FA2-O-C-H
H2C-O- P
2 fates of phosphatidate
Phosphatidate
H2C-O-FA1
CTP
Phosphatidate
phosphohydrolase
FA2-O-C-H
PPi
H2C-O- P
Diacylglycerol CDP-Diacylglycerol
H2C-O-FA1 H2C-O-FA1
FA2-O-C-H FA2-O-C-H
H2C-OH H2C-O- CDP
Synthesis of Triacylglycerol
Diacylglycerol CDP-Diacylglycerol
Phosphotidylserine
Summary
The synthesis of both triacylglycerol and
phospholipids starts with the conversion of Glycerol-
3-Phosphate to phosphatidate
Phosphatidate can be converted into either
diacylglycerol or CDP-diacylglycerol
CDP-diacylglycerol can be converted into
phophatidylinositol
Diacylglycerol is converted into either triacylglycerol
or phosphatidylcholine or phosphatidylethanolamine
Phosphatidylserine is made by replacing the choline
or ethanoline group with serine in the preformed
phospholipid
Lipid Transport
Adipose Tissue
Intestine
Liver Muscle
Cholesterol
cyclopentanoperhydro-
phenanthrene nucleus
OH
Lipid Transport
FA FA
FA
FA
cholesterol
ester
E PL
E cholesterol
E
protein
2) Lipoproteins
E TAG
Components of Lipoproteins
• Proteins
– Apolipoproteins (apo)
• Phospholipids
– Phosphatidylcholine most abundant
• Triacylglycerol
• Cholesterol
– Free cholesterol at surface
– Cholesterol ester (attached to fatty acid) in core
Lipoprotein Classes
• Lipoprotein classes differ in
– protein/lipid ratio
– phospholipid/cholesterol/cholesterol ester/
triacylglycerol ratio
– specific proteins present
• This leads to physical differences in
– size
– density
– charge
Major Lipoprotein Classes
Density (g/ml)
Water 1.000
Chylomicrons <1.006
VLDL <1.006
IDL 1.006-1.02
LDL 1.020-1.060
HDL 1.060-1.210
Composition of major human
lipoproteins
TAG Chol Chol Ester P’Lipid Protein
Chylos 90 2 3 3 2
VLDL 60 4 16 16 6
IDL 20 8 32 32 18
LDL 7 8 42 22 21
HDL2 5 5 20 26 44
HDL3 2 3 15 28 52
Apolipoproteins
• Diverse group of proteins that associated with
lipoproteins
• Wide ranges of sizes
– apoB100 – MW 550,000
– apoCI – MW 6,600
• While some (apoB48 & apoB100) remain
associated with same lipoprotein particle, most
(apos A,C,E) can transfer between lipoprotein
particles
Function of apolipoproteins
• Structural
– Hold particle together
– e.g. ApoB48 & ApoB100
• Enzyme activators or inhibitors
– e.g. Apo CII – activates lipoprotein lipase/
ApoCIII - inhibits
lipoprotein lipase
• Receptor recognition
– Recognised by receptors on the surface of cells
– e.g. ApoB100 recognised by LDL receptor
Major apolipoproteins
LDL
Endogenous Pathway
IDL
E
N
Chylomicrons
I
ST
VLDL
TE
IN
Remnants
Exogenous Pathway
LIVER
Nascent HDL
HDL3 HDL2
Reverse Cholesterol Transport Pathway
Lipoprotein metabolism
Exogenous Pathway
via lymph
INTESTINE chylomicron
capillary Energy in
muscle
Lipase
TAG in
adipose tissue
chylo
remnant LIVER
The Exogenous Pathway
Transport of dietary lipids
Dietary lipids are absorbed into the enterocytes
lining the small intestine
Phospholipid, Cholesterol, Cholesterol Ester &
TAG are incorporated with apolipoprotein (apo)
B48 to form chylomicrons
Over 90% of the mass of a chylomicron is TAG.
This means that these very large particles have a
very low density
Chylomicrons are secreted into the lymph and
then into the blood stream
The Exogenous Pathway
Transport of dietary lipids cont.
In the capillaries of adipose tissue and muscle the
chylomicrons become anchored to the enzyme
lipoprotein lipase (LPL)
LPL hydrolyses the TAG and releases fatty acids
which are taken up by the tissue
When most of the TAG has been broken down the
particle is released back into the circulation as a
chylomicron remnant
The cholesterol- rich remnant is removed from the
circulation after binding to receptors in the liver
Lipoprotein metabolism
Endogenous Pathway
VLDL LIVER
Energy in
muscle
Lipoprotein
Y
F.A VLDL Lipase
TAG in
adipose tissue Hepatic
IDL
Lipase
50%
50%
via lymph
chylomicron VLDL LIVER
INTESTINE
capillary Energy in
muscle
Lipoprotein
Y
Lipoprotein chylomicron F.A VLDL Lipase
Y
Lipase
TAG in
adipose tissue Hepatic
IDL
Lipase
50%
50%
chylo
remnant LIVER LDL Peripheral
80% 20% Tissues
Comparison of Exogenous &
Endogenous Pathways
Exogenous Endogenous
Tissue of origin Intestine Liver
Particle Chylomicron VLDL
Site of secretion Lymph/Blood Blood
Form of ApoB apoB48 apoB100
Remnant Chylo Remnant IDL/LDL
Site of uptake Liver Liver/Peripheral
Receptor LRP/LDL LDL
Ligand apoE apoE/apoB100
Newly-formed HDL is disc-shaped
Discoidal HDL
-LCAT C = cholesterol
| | | |
CC C C
LCAT
Cholesterol + Phospholipid → Cholesterol Ester + Lysophospholipid
(Cholesterol + FA) (Phospholipid – FA)
Conversion of discoidal HDL to spherical HDL
Discoidal HDL
-LCAT
| | | |
-C CC C C
-C
-C
-C
CE
LCAT- CE CE CE -C
CE
-C
-C
-C
HDL3
HDL3 continues to accumulate
Cholesterol Ester and becomes HDL2
HDL3
Tissue
cholesterol
HDL2
LIVER
Cholesterol is removed from HDL2 by the liver
through an interaction with cell surface receptors.
When it has lost most of its cholesterol ester it is
released back into the circulation as HDL3
HDL2 HDL3
CE
CE CE
LIVER CE
CE
CE
Reverse Cholesterol Transport
Transport of cholesterol from tissues to the liver
• Components produced by both the liver and
intestine come together to form Discoidal HDL
• Discoidal HDL rich in protein, phospholipid and
free cholesterol. It’s major protein is apoA1
• Discoidal HDL interacts with cells and picks up
cholesterol which is then esterified by LCAT
• This converts the particles into spherical HDL3
• Spherical HDL3 continues to accumulate
cholesterol and is converted into HDL2
• The excess cholesterol ester is removed from HDL2
by the liver and is converted back into HDL3
Lipoproteins and Heart Disease
LDL can deposit cholesterol in the arteries and
hence cause atherosclerosis which is the
underlying cause of heart attacks and stroke
HDL can remove cholesterol from the artery wall
and thus prevent or even reverse atherosclerosis
Thus the relative amount of LDL/HDL is an
important determinant of risk of developing
atherosclerosis
What happens to fatty acids when
they get into cells?
Fatty Acids
NEFA
Chylo
Remnant
secretion
lipid droplets
FA Esterification
(TAG & PL)
β-oxidation
(ketogenesis)
lipogenesis
Fatty Acid Metabolism in Muscle
Chylo/VLDL NEFA
FA
FA
-oxidation
Acetyl CoA
TCA Cycle
CO2 (+ATP)
Fatty Acids As A Source of Energy
Many tissues can oxidize fatty acids to produce
energy
– Muscle is quantitatively the most important
– Brain cannot utilize fatty acids but after prolonged
starvation it can use ketone bodies which are made
from fatty acids in the liver
Three sources of fatty acid for energy
– Released by LPL from chylomicrons
– Released by LPL from VLDL
– Released as NEFA from adipose tissue
Fatty Acid Oxidation
Linked to CoA before degradation
Acyl-CoA CoA
Carnitine Acyl-Carnitine
mitochondria
Carnitine Acyl-Carnitine
Acyl-CoA CoA
cytosol
movement catalyzed by cartine palmitoyltransferase
Fatty Acid Oxidation
R-CH2-(CH2-CH2)-CO-S-CoA
FAD FADH2 oxidation
H
R-CH2-(C=C)-CO-S-CoA
H
H2O hydration
HO H
R-CH2-(C - C)-CO-S-CoA
H H
NAD NADH2 oxidation
O
R-CH2-(C -CH2)-CO-S-CoA
Fatty Acid Oxidation cont.
O
R-CH2-C –(CH2-CO)-S-CoA
Thiolase
CoA-SH CH3-CO-S-CoA
Acetyl-CoA
R-CH2-CO-S-CoA
Acyl-CoA less
2 Carbons